Allianz Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.6M Buy
400,020
+37,901
+10% +$2.21M 0.03% 579
2025
Q4
$21.5M Buy
362,119
+346,865
+2,274% +$18.9M 0.02% 575
2025
Q3
$826K Sell
15,254
-8,587
-36% -$491K ﹤0.01% 1750
2025
Q2
$1.31M Sell
23,841
-13,026
-35% -$767K ﹤0.01% 1607
2025
Q1
$2.61M Buy
36,867
+8,252
+29% +$555K ﹤0.01% 1395
2024
Q4
$1.88M Buy
28,615
+1,782
+7% +$119K ﹤0.01% 1445
2024
Q3
$1.89M Sell
26,833
-55
-0.2% -$4.6K ﹤0.01% 1433
2024
Q2
$2.21M Buy
26,888
+5,330
+25% +$444K ﹤0.01% 1276
2024
Q1
$1.88M Sell
21,558
-16,486
-43% -$1.48M ﹤0.01% 1198
2023
Q4
$3.67M Sell
38,044
-6,807
-15% -$602K 0.01% 1073
2023
Q3
$3.97M Sell
44,851
-2,832
-6% -$252K 0.01% 1098
2023
Q2
$4.13M Buy
47,683
+1,092
+2% +$103K 0.01% 943
2023
Q1
$4.53M Buy
46,591
+23
+0% +$2.38K 0.01% 1012
2022
Q4
$4.82M Sell
46,568
-2,886
-6% -$271K 0.01% 925
2022
Q3
$4.19M Sell
49,454
-45,053
-48% -$4.01M 0.01% 955
2022
Q2
$7.83M Buy
94,507
+27,559
+41% +$2.19M 0.01% 962
2022
Q1
$5.16M Buy
66,948
+69
+0.1% +$5.77K ﹤0.01% 1214
2021
Q4
$5.92M Buy
66,879
+5,930
+10% +$489K ﹤0.01% 1168
2021
Q3
$4.71M Buy
60,949
+6,832
+13% +$539K ﹤0.01% 1300
2021
Q2
$4.51M Sell
54,117
-215,347
-80% -$17.1M ﹤0.01% 1167
2021
Q1
$20.3M Sell
269,464
-22,900
-8% -$1.87M 0.02% 616
2020
Q4
$25.6M Buy
292,364
+95,801
+49% +$7.6M 0.03% 535
2020
Q3
$15M Sell
196,563
-164,040
-45% -$16.6M 0.02% 655
2020
Q2
$44.5M Buy
360,603
+63,737
+21% +$6.33M 0.06% 364
2020
Q1
$25.1M Sell
296,866
-61,578
-17% -$5.31M 0.04% 473
2019
Q4
$30.3M Sell
358,444
-132,434
-27% -$10M 0.03% 599
2019
Q3
$33.1M Buy
490,878
+3,924
+0.8% +$302K 0.04% 575
2019
Q2
$41.7M Sell
486,954
-47,853
-9% -$4.09M 0.04% 491
2019
Q1
$47.5M Buy
534,807
+24,984
+5% +$2.32M 0.05% 415
2018
Q4
$43.3M Buy
509,823
+37,560
+8% +$3.57M 0.05% 407
2018
Q3
$45.8M Buy
472,263
+14,912
+3% +$1.49M 0.05% 466
2018
Q2
$43.1M Buy
457,351
+12,542
+3% +$1.1M 0.05% 466
2018
Q1
$36.1M Sell
444,809
-12,726
-3% -$1.09M 0.04% 574
2017
Q4
$40.8M Sell
457,535
-8,000
-2% -$696K 0.05% 630
2017
Q3
$43.3M Sell
465,535
-104,981
-18% -$9.28M 0.05% 575
2017
Q2
$51.6M Sell
570,516
-41,014
-7% -$3.73M 0.06% 472
2017
Q1
$53.8M Buy
611,530
+37,162
+6% +$3.31M 0.07% 455
2016
Q4
$47.6M Sell
574,368
-59,246
-9% -$5.09M 0.06% 566
2016
Q3
$58.7M Sell
633,614
-35,132
-5% -$3.31M 0.07% 382
2016
Q2
$52M Buy
668,746
+55,885
+9% +$4.75M 0.07% 392
2016
Q1
$50.5M Buy
612,861
+357,156
+140% +$29.1M 0.06% 359
2015
Q4
$26.9M Buy
255,705
+20,125
+9% +$2.1M 0.03% 614
2015
Q3
$24.8M Buy
235,580
+8,395
+4% +$1.12M 0.03% 623
2015
Q2
$31.1M Sell
227,185
-12,931
-5% -$1.6M 0.04% 606
2015
Q1
$29.9M Sell
240,116
-19,250
-7% -$2.04M 0.04% 542
2014
Q4
$23.4M Buy
259,366
+107,288
+71% +$8.92M 0.03% 643
2014
Q3
$11M Sell
152,078
-9,505
-6% -$625K 0.01% 804
2014
Q2
$10.1M Sell
161,583
-9,450
-6% -$571K 0.01% 735
2014
Q1
$11.7M Buy
171,033
+39,049
+30% +$2.88M 0.01% 712
2013
Q4
$9.28M Sell
131,984
-199,916
-60% -$13.6M 0.01% 758
2013
Q3
$24M Buy
331,900
+232,300
+233% +$15.4M 0.03% 478
2013
Q2
$5.55M Buy
+99,600
New +$6.21M 0.01% 860

Other funds holding BMRN